Heat shock protein 27 phosphorylation in the proliferation and apoptosis of human umbilical vein endothelial cells induced by high glucose through the phosphoinositide 3‑kinase/Akt and extracellular signal‑regulated kinase 1/2 pathways

Introduction

Diabetes mellitus is a serious threat to health and a predominant risk factor in the development of macro- and microvascular complications. Studies have shown that high glucose (HG) easily induces endothelial cell (EC) injury and apoptosis, which in turn results in diabetic vascular complications (1–4). EC apoptosis has also been closely associated with vascular disease.

Heat shock protein 27 (HSP27) is important in the regulation of proliferation and apoptosis in numerous cell types. Thus, HSP27 may be a potential target for the interventional treatment of pathological processes associated with cell proliferation and apoptosis (5,6). The phosphoinositide 3-kinase (PI3K)-Akt signaling pathway may promote EC proliferative dysfunction in diabetes. The mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK)signaling pathway is involved in proliferation and survival responses in ECs. Several studies (7–15) have shown that the MAPK/ERK and PI3K/Akt signaling pathways regulate the phosphorylation of HSP27. Another previous study has demonstrated that HSP27 phosphorylation is important in mediating the migration of vascular smooth muscle cells (VSMCs), and the MAPK/ERK and PI3K/Akt signaling pathways have also been revealed to regulate the phosphorylation of HSP27 in VSMCs (16,17). In the present study, the aim was to obtain information regarding the signal transduction pathways that regulate HSP27 phosphorylation, proliferation and apoptosis in human umbilical vein ECs (HUVECs) induced by HG.

Materials and methods

Isolation and culture of human ECs

HUVECs were isolated from the healthy umbilical veins of healthy female patients following laparotomy at the Fujian Provincial Hospital (Fuzhou, Fujian, China). The venous lumen was washed with sterile phosphate-buffered saline (PBS) 2–3 times and pre-warmed collagenase I (13–15 ml) was injected into the lumen, which was incubated for 20 min. The lumen was then washed using 30–40 ml sterile PBS. The wash-out was centrifuged at 155 × g for 10 min and the HUVECs were collected subsequent to discarding the supernatant. The cells were cultured in M199 medium with 20% fetal bovine serum (FBS). The cultures were maintained at 37°C with a gas mixture of 5% CO2:95% air. The primary cultures had the fluid changed 24 h after seeding and were subcultured on reaching confluence using 0.01% trypsin-EDTA (Sigma-Aldrich, St. Louis, MO, USA). The ECs were identified by direct immunostaining for factor VIII. The ECs from the third passages in an actively growing condition were used for experiments. The present study was conducted in accordance with the Declaration of Helsinki and with approval from the Ethics Committee of Fujian Provincial Clinical College (Fujian Medical University, Fuzhou, China). Written informed consent was obtained from all patients in this study.

alamarBlue® cell proliferation assay

HUVECs in a good growth condition were inoculated in 96-well plates with 6,000 cells/well and 150 μl cell culture medium was added to each well. The day following inoculation, the culture medium was changed to 60 μl M199 medium with 1% FBS, although the other components remained unchanged. When the cells had been cultured in a 37°C incubator for 10–15 h, 90 μl fresh M199 culture medium with 16% FBS was added. On the following day (within 24 h), D-glucose was added to the normal culture medium to obtain a final concentration of 30.5 mmol/l. The medium from the cells cultured with normal medium was changed every other day. The cells were incubated in a 37°C and 5% CO2 cell culture incubator. At 4 h before the end of culture, this medium was removed and 100 μl/well fresh M199 medium with 10% FBS and 10 μl/well alamarBlue® solution were added. The alamarBlue® cell proliferation assay was performed according to the kit manufacturer’s instructions (Merck & Co., White House Station, NJ, USA). The cells were incubated for 4 h at 37°C. The 570 and 600 nm absorbance optical density values of each well were examined with a microplate reader. The alamarBlue® reduction rates were calculated according to the manufacturer’s instructions. Five repeated wells were used at each time point.

Analysis of HUVEC apoptosis

The HUVEC cells were pretreated with quercetin, LY294002 or U0126 (Sigma-Aldrich) for 45 min before HG was added. At 48 h after treatment, 1–5×105 cells were collected using trypsin without EDTA. Following digestion, the cells were maintained in culture medium with serum to prevent further trypsin digestion. The cells were then washed twice in PBS, with centrifugation at 155 × g for 5 min, and resuspended in 500 μl binding buffer. Subsequently, 5 μl Annexin V-fluorescein isothiocyanate (FITC; Sigma-Aldrich) and 5 μl propidium iodide (PI; Biyuntian, Hangzhou, China) were added and the solutions were mixed. The mixture was incubated at room temperature for 10–15 min in a cool dark place. Annexin V-FITC binding was analyzed by flow cytometry (Ex=488 nm; Em=530 nm; Beckman Coulter, Carlsbad, CA, USA) using a FITC signal detector (usually FL1) and PI staining was examined using a phycoerythrin emission signal detector (usually FL2). Experiments were conducted in six-well plates and were repeated three times.

Western blotting

The HUVEC cells were pretreated with LY294002 (0.1, 1 or 10 μM) or U0126 (0.1, 1 or 10 μM) for 45 min before the addition of HG. Following treatment, HUVEC cells were washed with ice-cold PBS and then cellular proteins were obtained. Equal quantities of protein were then separated by 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes, which were incubated at room temperature in Tris-buffered saline and Tween 20 (TBST) containing 5% bovine serum albumin. Subsequent to blocking, the membranes were incubated with primary rabbit-anti-human phosphorylated-(p-)HSP27 antibody (1:300; Bioworld Technology, Inc., Minneapolis, MN, USA) and rat-anti-human total-HSP27 antibody (1:500; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) overnight at 4°C, followed by three washes (10 min each) with TBST. The membranes were then incubated with secondary antibody (goat anti-rabbit for p-HSP27 and goat anti-rat for total-HSP27; Biyuntian) at a dilution of 1:5,000 at room temperature for 70 min, followed by washing three times (10 min each) with TBST. The signals were detected using a chemiluminescence kit (Biyuntian) and quantified by densitometric analysis. Experiments were conducted in six-well plates and were repeated three times.

Statistical analysis

Statistical analysis was conducted using analysis of variance with SPSS 11.5 software (SPSS, Inc., Chicago, IL, USA). Values are expressed as the mean ± standard deviation.

Results

Effect of quercetin on HUVEC proliferation induced by HG

As shown in Fig. 1, compared with the normal controls, the HUVECs grown in HG exhibited significantly lower cell proliferation (P<0.01). The proliferation of HUVECs in HG was reduced by the specific HSP27 inhibitor quercetin in a concentration-dependent manner.

Figure 1 Effect of quercetin on the proliferation of human umbilical vein endothelial cells in response to high glucose (30.5 mmol/l). Bars: A, control; B, high glucose; C–E, quercetin (1, 10 and 100 μmol/l) + high glucose. #P<0.01 vs the control group; *P<0.01 vs. the high glucose group.

Effect of quercetin on the apoptosis of HUVECs induced by HG

As shown in Fig. 2, HG significantly promoted the apoptosis of HUVECs compared with the control (P<0.01). The apoptosis of HUVECs in HG was further induced by quercetin in a concentration-dependent manner.

Figure 2 Effects of quercetin on the apoptosis of human umbilical vein endothelial cells in response to high glucose (30.5 mmol/l). Bars: A, control; B, high glucose; C–E, quercetin (1, 10 and 100 μmol/l) + high glucose. #P<0.01 vs. the control group; *P<0.01 vs. the high glucose group. Apoptotic rate = apoptotic cells/total cells.

Effect of LY294002 and U0126 on HSP27 phosphorylation in HUVECs induced by HG

HSP27 phosphorylation induced by HG was blocked by the specific PI3K inhibitor LY294002 and the specific ERK1/2 inhibitor U0126 in a concentration-dependent manner. As shown in Figs. 3 and 4, HG induced significant increases in HSP27 phosphorylation compared with the control group (P<0.01). The peak inhibition rates of HSP27 phosphorylation induced by HG were 62.6 and 56.1% following 10 μM LY294002 and U0126 treatments, respectively (P<0.01 vs. the HG groups).

Figure 3 Concentration-dependent inhibitory effects of LY294002 (0.1–10 μmol/l) on HSP27 phosphorylation induced by high glucose (30.5 mmol/l) in human umbilical vein endothelial cells. Bars: A, control; B, high glucose; C–E, LY294002 (0.1–10 μmol/l) + high glucose. #P<0.01 vs. the control group; *P<0.01 vs. the high glucose group. HSP27, heat shock protein 27; P-, phosphorylated-.

Figure 4 Concentration-dependent inhibitory effects of U0126 (0.1–10 μmol/l) on HSP27 phosphorylation induced by high glucose (30.5 mmol/l) in human umbilical vein endothelial cells. Bars: A, control; B, high glucose; C–E, U0126 (0.1–10 μmol/l) + high glucose. #P<0.01 vs. the control group; **P<0.05 and *P<0.01 vs. the high glucose group. HSP27, heat shock protein 27; P-, phosphorylated-.

Effect of LY294002 and U0126 on HUVEC proliferation induced by HG

HUVECs grown in HG exhibited significantly inhibited cell proliferation compared with the normal control cells (P<0.01). The proliferation of HUVECs in HG was further inhibited by LY294002 and U0126, with peak inhibition rates of 51.4 and 60.0%, respectively (P<0.01 vs. the HG groups; Fig. 5).

Figure 5 Effects of LY294002 (10 μmol/l) and U0126 (10 μmol/l) on the proliferation of human umbilical vein endothelial cells in response to high glucose (30.5 mmol/l). Bars: A, control; B, high glucose; C, LY294002 + high glucose; D, U0126 + high glucose. #P<0.01 vs. the control group; *P<0.01 vs. the high glucose group.

Effect of LY294002 and U0126 on HUVEC apoptosis induced by HG

An incubation time period of 48 h was selected as an intervention time point and flow cytometry was used to detect HUVEC apoptosis. As shown in Fig. 6, compared with the normal control group, the HG group exhibited a significant increase in cell apoptosis (P<0.01). HUVEC apoptosis following HG was further increased by treatment with either LY294002 or U0126 (P<0.01 vs. the HG groups).

Figure 6 Effects of LY294002 (10 μmol/l) and U0126 (10 μmol/l) on the apoptosis of human umbilical vein endothelial cells in response to high glucose (30.5 mmol/l). Bars: A, control; B, high glucose; C, LY294002 + high glucose; D, U0126 + high glucose. #P<0.01 vs. the control group; *P<0.01 vs. the high glucose group. Apoptotic rate = apoptotic cells/total cells.

Discussion

Although HG has been reported to inhibit EC proliferation and increase apoptosis, the exact mechanism remains largely unknown. HSP27, with a molecular weight of ~27 kDa, has been shown to form large aggregates of ≤800 kDa in the cell cytosol. HSP27 expression is upregulated during the stress response and correlates with increased survival ability in cells exposed to cytotoxic stimuli. HSP27 has been shown to prevent the cell death caused by a variety of toxic agents that promote apoptosis. HSP27 is regulated by means of phosphorylation and dephosphorylation. Studies have shown that HSP27 is important in the regulation of proliferation and apoptosis in a number of cell types. HG is known to activate HSP27; however, since multiple signaling pathways are activated during HG-induced EC injury, the role of HSP27 activation in this process requires further clarification. Thus, in the present study, the effect of quercetin (the specific HSP27 inhibitor) on the proliferation and apoptosis of HUVECs induced by HG was examined.

A novel method for measuring cell proliferation, which uses alamarBlue®, has recently become available. alamarBlue® is a safe, nontoxic aqueous dye that is used to assess cell viability and cell proliferation. In the present study, the results of the alamarBlue® assay demonstrated the apparent toxic effects of HG on HUVECs and suggested that the specific HSP27 inhibitor quercetin may enhance the inhibition of HUVEC proliferation by HG.

Currently, apoptosis of ECs is considered to be an important cause of atherosclerosis during the development of diabetic chronic vascular diseases. A number of studies have observed that HG increases the rate of apoptosis in cultured HUVECs. The results of the present study revealed that co-administration of quercetin promoted the apoptosis of cultured HUVECs to a greater extent than HG alone, suggesting that HSP27 phosphorylation protects HUVECs from apoptosis. However, the underlying mechanism for this remains unclear. Long-term exposure to HG levels may induce several metabolic changes in ECs; these include negative feedback mechanisms that regulate upstream regulatory factors, which counteracts certain effects of glucose toxicity. This benefits the growth of ECs in HG culture. The present study demonstrated that the proliferation and apoptosis of HUVECs induced by HG was affected by quercetin in a concentration-dependent manner. Therefore, HSP27 phosphorylation may be part of an important signaling pathway that contributes to HUVEC proliferation and apoptosis induced by HG. Subsequently, the signal transduction pathways associated with HSP27 phosphorylation in HUVECs induced by HG were analyzed.

PI3K and Akt are downstream effectors of insulin signaling, and are important in ECs, as these signaling pathways regulate angiogenesis and proliferation (18). In ECs, Akt activation has been reported to promote cell survival (19,20). Studies have shown that the PI3K/Akt/nitric oxide signaling pathway is important in preventing reactive oxygen species-induced EC injury (21,22). However, whether the PI3K/Akt signaling pathway regulates the cell apoptosis induced by HG remains unclear. MAPK/ERK is an important signaling pathway involved in the regulation of various cellular processes, mainly proliferation and survival, but also apoptosis under particular pathological conditions (23). The MAPK/ERK signaling pathway is mainly involved in mediating growth factor-stimulated processes, such as division, growth, differentiation and survival in various cell types, including HUVECs.

The present study demonstrated that the HSP27 phosphorylation and cell proliferation induced by HG was blocked by the specific PI3K and ERK1/2 inhibitors LY294002 and U0126, and that the apoptosis of HUVECs in the LY294002 + HG and U0126 + HG groups was increased compared with the HG-only group. Therefore, PI3K/Akt and ERK1/2 may be important signaling pathways that contribute to HSP27 phosphorylation, and the proliferation and apoptosis of HUVECs in response to HG. In conclusion, the inhibition of the PI3K/Akt and ERK1/2 signal transduction pathways was found to contribute to the suppression of HSP27 phosphorylation and increased cell apoptosis. As determined by these findings, these two signaling pathways may be involved in the phosphorylation of HSP27 and HUVEC apoptosis in response to HG. Therefore, upregulation of the HSP27 signaling pathway may be considered as a target in future therapies protecting the diabetic patient from macrovascular complications. The present study provides further evidence that HSP27 functions within an anti-apoptotic signaling pathway and may indicate an alternative therapeutic method in the treatment of diabetic cardiovascular complications (24,25).

Acknowledgements

This study was supported by the Natural Science Foundation (grant no. 2013J01272) and the Key Clinical Speciality Discipline Construction Program of Fujian, China.

References